ArticleCancer letters2019

Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.

Katsuya Nagaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.